DR. LAURA ELIZABETH DURLING MD NPI 1689968133

NPI Details

DR. Laura Elizabeth Durling, MD is an internal medicine in Shenandoah, TX with 15 years of experience. The provider is a physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs. DR. Laura Elizabeth Durling, MD NPI is 1689968133. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE IN NEW ORLEANS
Graduation Year:2011

The provider's business location address is:

8845 SIX PINES DR STE 200
SHENANDOAH, TX
ZIP 77380-296
Phone: (281) 440-5300
Fax: (281) 943-6621

The NPI 1689968133 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Hemoglobin a1c level (HCPCS:83036)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99490)
• Vitamin d-3 level (HCPCS:82306)
• Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
• Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus (HCPCS:87426)
• Telephone medical discussion with physician, 5-10 minutes (HCPCS:99441)
• 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0004)
• Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
• Urine microalbumin (protein) level (HCPCS:82043)
• Creatinine level to test for kidney function or muscle injury (HCPCS:82570)
• Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
• Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
• Ferritin (blood protein) level (HCPCS:82728)
• Psa (prostate specific antigen) measurement, free (HCPCS:84154)
• Transferrin (iron binding protein) level (HCPCS:84466)
• Iron level (HCPCS:83540)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Folic acid level, serum (HCPCS:82746)
• Detection test by immunofluorescent technique for influenza b virus (HCPCS:87275)
• Detection test by immunofluorescent technique for influenza a virus (HCPCS:87276)
• Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) (HCPCS:87880)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen (HCPCS:87635)
• X-ray of chest, 2 views (HCPCS:71046)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Dxa bone density measurement of hip, pelvis, spine including spine fracture assessment (HCPCS:77085)
• Red blood count, automated test (HCPCS:85045)
• Administration of pneumococcal vaccine (HCPCS:G0009)
• Detection test by nucleic acid for multiple organisms, amplified probe(s) technique (HCPCS:87801)
• Blood test, clotting time (HCPCS:85610)
• Detection test by nucleic acid for multiple types influenza virus (HCPCS:87502)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Uric acid level, blood (HCPCS:84550)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Magnesium level (HCPCS:83735)
• Coagulation assessment blood test, plasma or whole blood (HCPCS:85730)
• Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use (HCPCS:90677)
• X-ray of lower and sacral spine, 2-3 views (HCPCS:72100)
• X-ray of shoulder, minimum of 2 views (HCPCS:73030)
• Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
• Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment (HCPCS:G0402)
• Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique (HCPCS:87640)
• Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique (HCPCS:87641)
• Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique (HCPCS:87500)
• Stool analysis for blood, by fecal hemoglobin determination by immunoassay (HCPCS:82274)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
• X-ray of upper spine, 2-3 views (HCPCS:72040)

The enumeration date for this NPI number is 6/1/2011 and was last updated on 9/11/2023.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.